MARKET

TTNP

TTNP

Titan Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3629
-0.0069
-1.87%
After Hours: 0.3629 0 0.00% 19:11 09/20 EDT
OPEN
0.3679
PREV CLOSE
0.3698
HIGH
0.3718
LOW
0.3375
VOLUME
748.01K
TURNOVER
--
52 WEEK HIGH
3.780
52 WEEK LOW
0.3301
MARKET CAP
5.71M
P/E (TTM)
-0.1830
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TTNP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

TTNP News

  • Titan Pharma 8-K Shows Co. Received Letter From Nasdaq Listing Qualifications Staff Notifying Co. It Is No Longer In Compliance With $1/Share Minimum Bid Price Requirement; Co. Has Until Mar. 17, 2020 To Regain Compliance
  • Benzinga.2d ago
  • Titan Pharma up 17% on new NIDA grant funding
  • Seeking Alpha - Article.4d ago
  • Titan Receives Approval For Second Year Of NIDA Grant Funding For Development Of A Nalmefene Implant
  • PR Newswire.4d ago
  • The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts
  • Benzinga.4d ago

More

Industry

Pharmaceuticals
+1.04%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About TTNP

Titan Pharmaceuticals, Inc. (Titan) is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Company's segment is engaged in the development of pharmaceutical products. The Company's product development programs utilize its long-term drug delivery platform, ProNeura. The Company's drug candidate, Probuphine, is being developed for the long-term maintenance treatment of opioid dependence. Titan's ProNeura continuous drug delivery system consists of a small, solid rod made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The Company focuses on developing two product development programs, the first one with a ropinirole implant for the treatment of Parkinson's disease (PD) and the second one with a Triiodothyronine (T3) implant for the treatment of hypothyroidism.
More

Webull offers Titan Pharmaceuticals, Inc. (TTNP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.